PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

McDonagh, Ellen M., Boukouvala, Sotiria, Aklillu, Eleni, Hein, David W., Altman, Russ B., Klein, Teri E.·2014·Pharmacogenetics and Genomics
DOI 10.1097/fpc.0000000000000062

Cites (203)

Items 201–203 of 203

  1. Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.
    J R Rashid, Kofi-Tsepko, F. D. Juma · 1992 · PubMed
  2. N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case–control studies
    Liang Zhang, Zhaolan Xiang, Rui Hao · 2013 · Tumor Biology
  3. A Four-SNP NAT2 Genotyping Panel Recommended to Infer Human Acetylator Phenotype
    David W. Hein, Mark A. Doll · 2012 · Pharmacogenomics